z-logo
Premium
Efficient synthesis of 13 C‐labelled erythromycin biosynthetic intermediate. 1: S ‐2‐acetylaminoethyl (2 R ,3 R ,4 R ,5 R )‐3,5‐diacetoxy‐2,4‐dimethyl‐4‐([ 13 C]methoxy)‐heptanethioate
Author(s) -
Iida Katsumi,
Kajiwara Masahiro,
InoueTanihata Tomoko,
Fukui Mineo,
Nakata Tadashi,
Oishi Takeshi
Publication year - 2008
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.1507
Subject(s) - chemistry , erythromycin , biosynthesis , stereochemistry , elongation , labelling , antibiotics , biochemistry , enzyme , metallurgy , ultimate tensile strength , materials science
An efficient 13 C‐labelling synthesis of the putative erythromycin biosynthetic intermediate, S ‐2‐acetylaminoethyl (2 R ,3 R ,4 R ,5 R )‐3,5‐diacetoxy‐2,4‐dimethyl‐4‐([ 13 C]methoxy)heptanethioate, which would be useful for the investigation of the chain elongation mechanism in erythromycin biosynthesis, was achieved by utilizing iodo[ 13 C]methane and (2 S ,3 R ,4 R ,5 R )‐4‐hydroxy‐3,5‐ O ‐isopropylidene‐2,4‐dimethylheptanol, obtained in our previous studies on erythromycin A synthesis. Copyright © 2008 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom